Top compounds associated with response to TTK


Feature Type Standardized
Nominal ANOVA
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.17 4e-08
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.16 3e-07
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC -0.17 3e-07
mRNA FK866 CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.14 1e-06
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA nelarabine CTRPv2 pan-cancer AAC 0.17 8e-06
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.15 8e-06
Download CSV